Telomerase and breast cancer
Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in n...
Kaydedildi:
| Yayımlandı: | Breast Cancer Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2001
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11305948/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr288 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|